A Large Multi-Ethnic Genome-Wide Association Study of Adult Body Mass Index Identifies

Total Page:16

File Type:pdf, Size:1020Kb

A Large Multi-Ethnic Genome-Wide Association Study of Adult Body Mass Index Identifies Genetics: Early Online, published on August 14, 2018 as 10.1534/genetics.118.301479 1 A large multi-ethnic genome-wide association study of adult body mass index identifies 2 novel loci 3 4 Thomas J Hoffmann*,†,1, Hélène Choquet‡, Jie Yin‡, Yambazi Banda*, Mark N Kvale*, 5 Maria Glymour†, Catherine Schaefer‡, Neil Risch*,†,‡, and Eric Jorgenson‡,1 6 7 *Institute for Human Genetics, University of California San Francisco, San Francisco, 8 CA, 94143 9 †Department of Epidemiology and Biostatistics, University of California San Francisco, 10 San Francisco, CA 94158 11 ‡Division of Research, Kaiser Permanente, Northern California, Oakland, CA 94612 12 13 GO Project IRB: CN-09CScha-06-H. 14 15 1 Copyright 2018. 16 Short running title: GWAS of BMI 17 18 Keywords: adult body mass index; adult BMI; genome-wide association study; obesity 19 20 1Corresponding authors: Eric Jorgenson, Division of Research, Kaiser Permanente, 21 Northern California, 2000 Broadway, Oakland, CA 94612, Tel: 510-891-3473, e-mail: 22 [email protected], or Thomas J. Hoffmann, University of California San Francisco, 23 513 Parnassus Ave, San Francisco, CA 94117, Tel: 415-476-2475, e-mail: 24 [email protected]. 25 2 26 Abstract 27 Body mass index (BMI), a proxy measure for obesity, is determined by both 28 environmental (including ethnicity, age, and sex) and genetic factors with over 400 BMI- 29 associated loci identified to date. However, the impact, interplay, and underlying 30 biological mechanisms among BMI, environment, genetics, and ancestry are not 31 completely understood. To further examine these relationships, we utilized 427,509 32 calendar-year averaged BMI measurements on 100,418 adults from the single large 33 multi-ethnic Genetic Epidemiology Research on Adult Health and Aging (GERA) cohort. 34 We observed substantial independent ancestry and nationality differences, including 35 ancestry principal component interactions and non-linear effects. To increase the list of 36 BMI-associated variants before assessing other differences, we conducted a genome- 37 wide association study (GWAS) in GERA, with replication in Genetic Investigation of 38 Anthropomorphic Traits (GIANT) combined with UK Biobank (UKB), followed by GWAS 39 in GERA combined with GIANT, with replication in UKB. We discovered 30 novel 40 independent BMI loci (P<5.0x10-8) that replicated. We then assessed in UKB the 41 proportion of BMI variance explained by sex using previously- compared to previously- 42 and newly-identified loci and found slight increases: from 3.0% to 3.3% for males, and 43 from 2.7% to 3.0% for females. Further, the variance explained by previously- and 44 newly-identified variants decreased with increasing age in GERA and UKB, echoed in 45 the variance explained by the entire genome, which also showed gene-age interaction 46 effects. Finally, we conducted a tissue eQTL enrichment analysis, which revealed that 47 GWAS BMI-associated variants were enriched in the cerebellum, consistent with prior 48 work in humans and mice. 3 49 Introduction 50 Body mass index (BMI) is a proxy measure for obesity, and high BMI (≥30 kg/m2) 51 increases the risk of many health problems (Bhaskaran et al. 2014; Ortega et al. 2016; 52 Benjamin et al. 2017). BMI is determined by both genetic and environmental factors, 53 though their individual and combined contributions to risk are not completely 54 understood. Recent BMI heritability estimates are around 40%, over half of which is due 55 to common genetic variation (Hemani et al. 2013; Yang et al. 2015). To date, meta- 56 analyses of genome-wide association studies (GWAS) have identified 426 independent 57 BMI-associated variants (Liu et al. 2008; Thorleifsson et al. 2009; Willer et al. 2009; 58 Speliotes et al. 2010; Kim et al. 2011; Okada et al. 2012; Wen et al. 2012, 2014; Ng et 59 al. 2012, 2017; Yang et al. 2012, 2014; Berndt et al. 2013; Monda et al. 2013; Gong et 60 al. 2013; Scannell Bryan et al. 2014; Locke et al. 2015; Horikoshi et al. 2015; Winkler et 61 al. 2015; Hägg et al. 2015; Minster et al. 2016; Ried et al. 2016; Ahmad et al. 2016; 62 Wang et al. 2016; Salinas et al. 2016; Bakshi et al. 2016; Nagy et al. 2017; Justice et al. 63 2017; Graff et al. 2017; Tachmazidou et al. 2017; Akiyama et al. 2017; Turcot et al. 64 2018), and 676 independent variants associated with measures of adiposity 65 phenotypes, including BMI (Scuteri et al. 2007; Chambers et al. 2008; Meyre et al. 66 2009; Heard-Costa et al. 2009; Lindgren et al. 2009; Cotsapas et al. 2009; Scherag et 67 al. 2010; Heid et al. 2010; Kraja et al. 2011; Wang et al. 2011; Kilpeläinen et al. 2011; 68 Jiao et al. 2011; Paternoster et al. 2011; Comuzzie et al. 2012; Melka et al. 2012; 69 Bradfield et al. 2012; Liu et al. 2013; Namjou et al. 2013; Wheeler et al. 2013; Graff et 70 al. 2013; Pei et al. 2014, 2017; Shungin et al. 2015; Felix et al. 2016; Wen et al. 2016; 71 Sung et al. 2016; Chu et al. 2017; Southam et al. 2017). These variants account for only 4 72 ~3% of the variance for this complex trait (Speliotes et al. 2010; Wen et al. 2014; Locke 73 et al. 2015; Horikoshi et al. 2015). The vast majority of these loci were identified in 74 studies of European- or Asian-ancestry (Okada et al. 2012; Wen et al. 2012, 2014; 75 Scannell Bryan et al. 2014; Yang et al. 2014; Justice et al. 2017; Graff et al. 2017; 76 Akiyama et al. 2017; Turcot et al. 2018) populations, as sample sizes have been 77 somewhat smaller in Hispanic/Latino- (Salinas et al. 2016) or African-ancestry 78 populations (Ng et al. 2012, 2017; Monda et al. 2013; Gong et al. 2013; Salinas et al. 79 2016). Previous work has implicated ancestral differences, with some conflicting results 80 (Hu et al. 2015), but has not yet assessed ancestry variation within nationality 81 subgroups. 82 Gene-environment interaction may explain an additional portion of the missing 83 heritability. Previous work has discovered several variants differ between sexes (Locke 84 et al. 2015) and age (Winkler et al. 2015), as well as overall heritability differences in 85 age (Robinson et al. 2017), but found that this was driven only by young (ages 18-40) 86 vs. old (age≥60) in the AHTHEL cohort, with no evidence of interaction between ages 87 46-73 in the UK Biobank (UKB). 88 To further investigate the relationships among BMI, ancestry, sex, and age, we 89 utilized 427,509 calendar-year average BMI measurements from electronic health 90 records (EHRs) to 100,418 members from the Genetic Epidemiology Research in Adult 91 Health and Aging (GERA) cohort. Our goal was to utilize advantages of having a single 92 large multiethnic cohort to obtain a more comprehensive picture of the genetic 93 landscape of BMI. To this end, we first comprehensively assessed ancestry and 94 nationality effects on BMI in GERA. Then, in order to test for ancestry differences in 5 95 polygenic risk factors and further characterize SNPs, including age and sex differences, 96 we first attempted to increase the list of associated variants by searching for additional 97 BMI-associated variants in GERA, and further meta-analyzed GERA with Genetic 98 Investigation of Anthropomorphic Traits (GIANT) for improved discovery. We then used 99 previously-reported plus our novel variants to test for age, sex, and ancestry 100 differences, by both testing the individual variants themselves and testing them together 101 in polygenic risk scores and through gene-age co-heritability estimates. 102 6 103 Materials and Methods 104 All statistical tests were two-sided. 105 106 Participants and phenotype 107 Our primary analysis used data on adult RPGEH GERA cohort participants (Banda et 108 al. 2015; Kvale et al. 2015) who were, on average, 62.7 yr old (at specimen collection) 109 and members of KPNC for 23 yr, and had comprehensive electronic health records 110 (EHR) available for retrieval of height and weight. Each individual's height was 111 calculated as the mode (or median if no mode), and outpatient weight measurements 112 from 2005-2010 were averaged within each calendar year, excluding outlier weights <70 113 or >500 pounds (<31.7 or >226.8 kgs). Within a calendar year, if the range exceeded 114 100 pounds (45.3 kgs) (3,759 occurrences), weights ≥75 pounds (34.0 kgs) from the 115 median were discarded. Across calendar years, if a difference between the average of 116 two consecutive years was >175 lbs (79.4 kgs), the one further from the median was 117 excluded. BMI was calculated by definition, weight (kg) / height (m)2. We further 118 excluded BMI measures <10 or >100 kg/m2, where age <18 yr, 6 months prior/after 119 childbirth, or after bariatric surgery. In total, 427,509 calendar-year BMI measurements 120 were available on 100,418 individuals. To define nationality/geography within ethnicity 121 groups, participants endorsed all applicable from 23 groups (Banda et al. 2015). The 122 Kaiser Permanente Northern California Institutional Review Board and the University of 123 California San Francisco Human Research Protection Program Committee on Human 124 Health approved of this project. Written informed consent was obtained from all 125 subjects. 7 126 127 Genotyping, quality control, and imputation 128 Individuals were genotyped at over 650,000 single nucleotide polymorphisms (SNPs) on 129 four custom Affymetrix arrays optimized for individuals of European, Latino, East Asian 130 and African American ancestry (Hoffmann et al. 2011a; b), and South Asians were 131 genotyped on the European array.
Recommended publications
  • Tepzz 8Z6z54a T
    (19) TZZ ZZ_T (11) EP 2 806 054 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 26.11.2014 Bulletin 2014/48 C40B 40/06 (2006.01) C12Q 1/68 (2006.01) C40B 30/04 (2006.01) C07H 21/00 (2006.01) (21) Application number: 14175049.7 (22) Date of filing: 28.05.2009 (84) Designated Contracting States: (74) Representative: Irvine, Jonquil Claire AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HGF Limited HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL 140 London Wall PT RO SE SI SK TR London EC2Y 5DN (GB) (30) Priority: 28.05.2008 US 56827 P Remarks: •Thecomplete document including Reference Tables (62) Document number(s) of the earlier application(s) in and the Sequence Listing can be downloaded from accordance with Art. 76 EPC: the EPO website 09753364.0 / 2 291 553 •This application was filed on 30-06-2014 as a divisional application to the application mentioned (71) Applicant: Genomedx Biosciences Inc. under INID code 62. Vancouver, British Columbia V6J 1J8 (CA) •Claims filed after the date of filing of the application/ after the date of receipt of the divisional application (72) Inventor: Davicioni, Elai R.68(4) EPC). Vancouver British Columbia V6J 1J8 (CA) (54) Systems and methods for expression- based discrimination of distinct clinical disease states in prostate cancer (57) A system for expression-based discrimination of distinct clinical disease states in prostate cancer is provided that is based on the identification of sets of gene transcripts, which are characterized in that changes in expression of each gene transcript within a set of gene transcripts can be correlated with recurrent or non- recur- rent prostate cancer.
    [Show full text]
  • Supplemental Materials and Methods Page
    1 2 Supplementary Information for 3 4 5 Vertebrate adaptive radiation is assembled from an ancient and disjunct spatiotemporal 6 landscape 7 8 Emilie J. Richards, Joseph A. McGirr, Jeremy R. Wang, Michelle E. St. John, Jelmer W. 9 Poelstra, Maria J. Solano, Delaney C. O’Connell, Bruce J. Turner, Christopher H. Martin* 10 11 *Correspondence to: [email protected] 12 13 14 15 This PDF file includes: 16 17 Supplementary text 18 Figures S1 to S17 19 Tables S1 to S19 20 SI References 21 22 Other supplementary materials for this manuscript include the following: 23 24 Datasets S1 to S9 25 26 27 28 29 30 31 32 33 34 35 36 37 1 38 Table of Contents 1. Supplemental Materials and Methods Page 1.1 Sampling 4 1.2 Genomic Library Prep 5 1.3 De novo genome assembly and annotation 5 1.4 Population genotyping. 6 1.5 Population genetic analyses 8 1.6 Mutation rate estimation. 10 1.7 Demographic Inferences 12 1.8 Introgression in SSI specialists 13 1.9 Search for candidate adaptive alleles in SSI specialists 15 1.10 Introgression in outgroup generalist populations 18 1.11. Characterization of adaptive alleles through GO analysis 19 1.12 Characterization of adaptive alleles through genome-wide association mapping 19 1.13 Characterization of adaptive alleles through differential gene expression and QTL 22 analysis from previous studies 1.14 Timing of divergence among adaptive alleles 23 1.15 Timing of selective sweeps on adaptive alleles 26 2. Supplementary Results and Discussion 31 2 2.1 Spatiotemporal stages of adaption based on timing of divergence among adaptive alleles 31 2.2 Spatiotemporal stages of adaptation based on timing of selection on adaptive alleles 35 3.
    [Show full text]
  • WO 2014/172046 A9 O
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) CORRECTED VERSION (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2014/172046 A9 23 October 2014 (23.10.2014) P C T (51) International Patent Classification: 61/824,253 16 May 2013 (16.05.2013) US C12Q 1/68 (2006.01) G06F 19/20 (201 1.01) 61/860,1 15 30 July 201 3 (30.07.2013) US 61/907,939 22 November 2013 (22. 11.2013) us (21) International Application Number: 61/915,392 12 December 2013 (12. 12.2013) us PCT/US2014/029592 61/935,650 4 February 2014 (04.02.2014) us (22) International Filing Date: 61/940,226 14 February 2014 (14.02.2014) us 14 March 2014 (14.03.2014) (71) Applicant: LIFE TECHNOLOGIES CORPORATION (25) Filing Language: English [US/US]; Legal Department, Intellectual Property, 5791 Van Allen Way, Carlsbad, California 92008 (US). (26) Publication Language: English (72) Inventors: RHODES, Daniel; Life Technologies Corpora (30) Priority Data: tion, Legal Department, Intellectual Property, 5791 Van 61/813,182 17 April 2013 (17.04.2013) Allen Way, Carlsbad, California 92008 (US). SADIS, 61/813,465 18 April 2013 (18.04.2013) Seth; Life Technologies Corporation, Legal Department, [Continued on nextpage] (54) Title: GENE FUSIONS AND GENE VARIANTS ASSOCIATED WITH CANCER (57) Abstract: The disclosure provides gene fusions, gene variants, and novel as sociations with disease states, as well as kits, probes, and methods of using the same. raw cells Annotate and Filter Fusions 424K annotated fusion cells Summarize and Prioritize Fusions Gene Fusion RNASeq data < processing workflow o w o 2014/172046 A 9 1I II II I III IIII II 11lll l ll III! Ill III II Intellectual Property, 5791 Van Allen Way, Carlsbad, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, California 92008 (US).
    [Show full text]
  • A Large Multiethnic Genome-Wide Association Study of Adult Body Mass Index Identifies Novel Loci
    | INVESTIGATION A Large Multiethnic Genome-Wide Association Study of Adult Body Mass Index Identifies Novel Loci Thomas J. Hoffmann,*,†,1 Hélène Choquet,‡ Jie Yin,‡ Yambazi Banda,* Mark N. Kvale,* Maria Glymour,† Catherine Schaefer,‡ Neil Risch,*,†,‡ and Eric Jorgenson‡,1 *Institute for Human Genetics, University of California San Francisco, California 94143, †Department of Epidemiology and Biostatistics, University of California San Francisco, California 94158, and ‡Division of Research, Kaiser Permanente Northern California, Oakland, California 94612 ORCID ID: 0000-0001-9839-8667 (H.C.) ABSTRACT Body mass index (BMI), a proxy measure for obesity, is determined by both environmental (including ethnicity, age, and sex) and genetic factors, with . 400 BMI-associated loci identified to date. However, the impact, interplay, and underlying biological mechanisms among BMI, environment, genetics, and ancestry are not completely understood. To further examine these relationships, we utilized 427,509 calendar year-averaged BMI measurements from 100,418 adults from the single large multiethnic Genetic Epide- miology Research on Adult Health and Aging (GERA) cohort. We observed substantial independent ancestry and nationality differences, including ancestry principal component interactions and nonlinear effects. To increase the list of BMI-associated variants before assessing other differences, we conducted a genome-wide association study (GWAS) in GERA, with replication in the Genetic Investigation of Anthropomorphic Traits (GIANT) consortium combined with the UK Biobank (UKB), followed by GWAS in GERA combined with GIANT, with replication in the UKB. We discovered 30 novel independent BMI loci (P , 5.0 3 1028) that replicated. We then assessed the proportion of BMI variance explained by sex in the UKB using previously identified loci compared to previously and newly identified loci and found slight increases: from 3.0 to 3.3% for males and from 2.7 to 3.0% for females.
    [Show full text]
  • Multi-Ancestry GWAS of the Electrocardiographic PR Interval Identifies 210 Loci Underlying
    bioRxiv preprint doi: https://doi.org/10.1101/712398; this version posted July 30, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Multi-ancestry GWAS of the electrocardiographic PR interval identifies 210 loci underlying 2 cardiac conduction 3 4 Ioanna Ntalla1*, Lu-Chen Weng2, 3*, James H. Cartwright1, Amelia Weber Hall2, 3, Gardar 5 Sveinbjornsson4, Nathan R. Tucker2, 3, Seung Hoan Choi3, Mark D. Chaffin3, Carolina Roselli3, 5 , 6 Michael R. Barnes1, 6, Borbala Mifsud1, 7, Helen R. Warren1, 6, Caroline Hayward8, Jonathan 7 Marten8, James J. Cranley1, Maria Pina Concas9, Paolo Gasparini9, 10, Thibaud Boutin8, Ivana 8 Kolcic11, Ozren Polasek11-13, Igor Rudan14, Nathalia M. Araujo15, Maria Fernanda Lima-Costa16, 9 Antonio Luiz P. Ribeiro17, Renan P. Souza15, Eduardo Tarazona-Santos15, Vilmantas Giedraitis18, 10 Erik Ingelsson19-22, Anubha Mahajan23, Andrew P. Morris23-25, Fabiola Del Greco M.26, Luisa 11 Foco26, Martin Gögele26, Andrew A. Hicks26, James P. Cook24, Lars Lind27, Cecilia M. Lindgren28- 12 30, Johan Sundström31, Christopher P. Nelson32, 33, Muhammad B. Riaz32, 33, Nilesh J. Samani32, 33, 13 Gianfranco Sinagra34, Sheila Ulivi9, Mika Kähönen35, 36, Pashupati P. Mishra37, 38, Nina 14 Mononen37, 38, Kjell Nikus39, 40, Mark J. Caulfield1, 6, Anna Dominiczak41, Sandosh 15 Padmanabhan41, 42, May E. Montasser43, 44, Jeff R. O'Connell43, 44, Kathleen Ryan43, 44, Alan R. 16 Shuldiner43, 44, Stefanie Aeschbacher45, David Conen45, 46, Lorenz Risch47-49, Sébastien Thériault46, 17 50, Nina Hutri-Kähönen51, 52, Terho Lehtimäki37, 38, Leo-Pekka Lyytikäinen37-39, Olli T.
    [Show full text]
  • 1 Supplementary Material Figure S1. Volcano Plot of Differentially
    Supplementary material Figure S1. Volcano Plot of differentially expressed genes between preterm infants fed own mother’s milk (OMM) or pasteurized donated human milk (DHM). Table S1. The 10 most representative biological processes filtered for enrichment p- value in preterm infants. Biological Processes p-value Quantity of DEG* Transcription, DNA-templated 3.62x10-24 189 Regulation of transcription, DNA-templated 5.34x10-22 188 Transport 3.75x10-17 140 Cell cycle 1.03x10-13 65 Gene expression 3.38x10-10 60 Multicellular organismal development 6.97x10-10 86 1 Protein transport 1.73x10-09 56 Cell division 2.75x10-09 39 Blood coagulation 3.38x10-09 46 DNA repair 8.34x10-09 39 Table S2. Differential genes in transcriptomic analysis of exfoliated epithelial intestinal cells between preterm infants fed own mother’s milk (OMM) and pasteurized donated human milk (DHM). Gene name Gene Symbol p-value Fold-Change (OMM vs. DHM) (OMM vs. DHM) Lactalbumin, alpha LALBA 0.0024 2.92 Casein kappa CSN3 0.0024 2.59 Casein beta CSN2 0.0093 2.13 Cytochrome c oxidase subunit I COX1 0.0263 2.07 Casein alpha s1 CSN1S1 0.0084 1.71 Espin ESPN 0.0008 1.58 MTND2 ND2 0.0138 1.57 Small ubiquitin-like modifier 3 SUMO3 0.0037 1.54 Eukaryotic translation elongation EEF1A1 0.0365 1.53 factor 1 alpha 1 Ribosomal protein L10 RPL10 0.0195 1.52 Keratin associated protein 2-4 KRTAP2-4 0.0019 1.46 Serine peptidase inhibitor, Kunitz SPINT1 0.0007 1.44 type 1 Zinc finger family member 788 ZNF788 0.0000 1.43 Mitochondrial ribosomal protein MRPL38 0.0020 1.41 L38 Diacylglycerol
    [Show full text]
  • Identification of Host Factors Associated with the Development Of
    viruses Article Identification of Host Factors Associated with the Development of Equine Herpesvirus Myeloencephalopathy by Transcriptomic Analysis of Peripheral Blood Mononuclear Cells from Horses Lila M. Zarski 1, Kim S. Giessler 1, Sarah I. Jacob 1 , Patty Sue D. Weber 2, Allison G. McCauley 1, Yao Lee 1 and Gisela Soboll Hussey 1,* 1 Department of Pathobiology and Diagnostic Investigation, Michigan State University, East Lansing, MI 48824, USA; [email protected] (L.M.Z.); [email protected] (K.S.G.); [email protected] (S.I.J.); [email protected] (A.G.M.); [email protected] (Y.L.) 2 Department of Large Animal Clinical Sciences, Michigan State University, East Lansing, MI 48824, USA; [email protected] * Correspondence: [email protected] Abstract: Equine herpesvirus-1 is the cause of respiratory disease, abortion, and equine herpesvirus myeloencephalopathy (EHM) in horses worldwide. EHM affects as many as 14% of infected horses and a cell-associated viremia is thought to be central for EHM pathogenesis. While EHM is infrequent Citation: Zarski, L.M.; Giessler, K.S.; in younger horses, up to 70% of aged horses develop EHM. The aging immune system likely con- Jacob, S.I.; Weber, P.S.D.; McCauley, tributes to EHM pathogenesis; however, little is known about the host factors associated with clinical A.G.; Lee, Y.; Soboll Hussey, G. EHM. Here, we used the “old mare model” to induce EHM following EHV-1 infection. Peripheral Identification of Host Factors blood mononuclear cells (PBMCs) of horses prior to infection and during viremia were collected Associated with the Development of and RNA sequencing with differential gene expression was used to compare the transcriptome of Equine Herpesvirus horses that did (EHM group) and did not (non-EHM group) develop clinical EHM.
    [Show full text]
  • Towards Retinal Repair: Analysis of Photoreceptor Precursor Cells and Their Cell Surface Molecules
    Towards retinal repair: analysis of photoreceptor precursor cells and their cell surface molecules Ya-Ting Han University College London Institute of Child Health A thesis submitted for the degree of Philosophiae Doctor For the incredible cells that drive me here. ii Acknowledgements I would like to firstly thank my supervisor Prof. Jane Sowden for her consistent support, encouragement and advice throughout my PhD. I still remember when I just started my PhD and wanted some dendritic cells in a control experiment for some even not so exciting markers, Jane instantly contacted her colleagues to provide me these cells. Cases as such are countless. I have been encouraged to develop my own research ideas and Jane has always been supporting. It is through all these that I confidently and happily conducted my studies here. I am very happy that I chose the right supervisor. Thank you, Jane! I would also like to thank my secondary supervisor Prof. Robin Ali for his encouragements throughout, Dr. Janny Morgan for her advice during my PhD upgrade, Prof. Andy Copp, Prof. David Muller, Dr. Kenth Gustafsson, Dr. Andy Stoker, Dr. Juan-Pedro Martinez-Barbera, and Dr. Patrizia Ferretti for helpful discussion and advices. Thanks to Dr. Kevin Mills and Dr. Wendy Heywood for their supports with mass spectrometry, especially Wendy for her unlimited kind and generous help during all my time with mass spectrometry. Thanks to Dan who helped and advised me in molecular cloning. Thanks to Rachael who performed all the injections for cell transplantation. Thanks to Jorn who showed me the techniques when I just entered the lab and helped me with my first cell transplantation.
    [Show full text]
  • Genes by Expressed Sequence Tag Profiling Genome-Wide Analysis Of
    The Journal of Immunology Genome-wide Analysis of Immune System Genes by Expressed Sequence Tag Profiling Cosmas C. Giallourakis,*,†,1 Yair Benita,*,†,‡,1 Benoit Molinie,*,† Zhifang Cao,*,†,‡ Orion Despo,*,† Henry E. Pratt,*,† Lawrence R. Zukerberg,x Mark J. Daly,{,k John D. Rioux,# and Ramnik J. Xavier*,†,‡,{,k Profiling studies of mRNA and microRNA, particularly microarray-based studies, have been extensively used to create compendia of genes that are preferentially expressed in the immune system. In some instances, functional studies have been subsequently pursued. Recent efforts such as the Encyclopedia of DNA Elements have demonstrated the benefit of coupling RNA sequencing analysis with information from expressed sequence tags (ESTs) for transcriptomic analysis. However, the full characterization and identification of transcripts that function as modulators of human immune responses remains incomplete. In this study, we demonstrate that an integrated analysis of human ESTs provides a robust platform to identify the immune transcriptome. Be- yond recovering a reference set of immune-enriched genes and providing large-scale cross-validation of previous microarray stud- ies, we discovered hundreds of novel genes preferentially expressed in the immune system, including noncoding RNAs. As a result, we have established the Immunogene database, representing an integrated ESTroad map of gene expression in human immune cells, which can be used to further investigate the function of coding and noncoding genes in the immune system. Using this approach, we have uncovered a unique metabolic gene signature of human macrophages and identified PRDM15 as a novel overexpressed gene in human lymphomas. Thus, we demonstrate the utility of EST profiling as a basis for further deconstruction of physiologic and pathologic immune processes.
    [Show full text]
  • Ectopic Protein Interactions Within BRD4–Chromatin Complexes Drive
    Ectopic protein interactions within BRD4–chromatin PNAS PLUS complexes drive oncogenic megadomain formation in NUT midline carcinoma Artyom A. Alekseyenkoa,b,1, Erica M. Walshc,1, Barry M. Zeea,b, Tibor Pakozdid, Peter Hsic, Madeleine E. Lemieuxe, Paola Dal Cinc, Tan A. Incef,g,h,i, Peter V. Kharchenkod,j, Mitzi I. Kurodaa,b,2, and Christopher A. Frenchc,2 aDivision of Genetics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115; bDepartment of Genetics, Harvard Medical School, Boston, MA 02115; cDepartment of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115; dDepartment of Biomedical Informatics, Harvard Medical School, Boston, MA 02115; eBioinfo, Plantagenet, ON, Canada K0B 1L0; fDepartment of Pathology, University of Miami Miller School of Medicine, Miami, FL 33136; gBraman Family Breast Cancer Institute, University of Miami Miller School of Medicine, Miami, FL 33136; hInterdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL 33136; iSylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136; and jHarvard Stem Cell Institute, Cambridge, MA 02138 Contributed by Mitzi I. Kuroda, April 6, 2017 (sent for review February 7, 2017; reviewed by Sharon Y. R. Dent and Jerry L. Workman) To investigate the mechanism that drives dramatic mistargeting of and, in the case of MYC, leads to differentiation in culture (2, 3). active chromatin in NUT midline carcinoma (NMC), we have Similarly, small-molecule BET inhibitors such as JQ1, which identified protein interactions unique to the BRD4–NUT fusion disengage BRD4–NUT from chromatin, diminish megadomain- oncoprotein compared with wild-type BRD4.
    [Show full text]
  • Pediátricas Nome Modelo Idade 40 Sexo F Data De Emissão 10-04-2020
    Pediátricas Nome Modelo Idade 40 Sexo F Data de Emissão 10-04-2020 Prescritor Modelo Convenio Modelo Nossa metodologia: Sequenciamento do Genoma Inteiro Humano - WGS O WGS está inaugurando uma nova era, a da verdadeira Medicina Personalizada, Preditiva e Preventiva, ao realizar o sequenciamento do genoma total. A tecnologia WGS, utilizada pela FULLDNA, permite, a partir de resultados indiscutíveis, detalhados e específicos de variantes genéticas, a criação de uma Identidade Genética Personalizada de cada pessoa, composta de suas Características, Necessidades e Suscetibilidades genéticas, além de se poder gerar, a partir das análises, Tratamentos Geneticamente Personalizados, pois os avanços com a tecnologia WGS já estão permitindo a orientação de tratamentos para cânceres comuns (como câncer colorretal e melanoma) e determinação de quais medicamentos são seguros (e quais não são) para cada pessoa. A WGS é uma excepcional inovação tecnológica por executar o sequenciamento do genoma inteiro com expressiva eficiência. Quando comparado com tecnologias parciais de DNA autossômico, como o teste de DNA autossômico com microarrays ou sequenciamento de exoma (1% do genoma), a tecnologia WGS da FULLDNA fornece 3.000 vezes mais informações por fornecer dados sobre todos os seis bilhões de pares de bases do genoma humano. Ela fornece cobertura completa das regiões codificadoras e não codificadoras do genoma e variantes de um único nucleotídeo, inserções/deleções, alterações no número de cópias e grandes variantes estruturais, além da determinação das variações no número de cópias, rearranjos e outras variações estruturais. Com a utilização da tecnologia WGS, a FULLDNA realiza hoje a análise mais completa e única no mundo, o que oferece ao profissional de saúde e a cada pessoa um potencial preditivo e preventivo também único.
    [Show full text]
  • Supplementary Table 1. a Full List of Cancer Genes
    Supplementary Table 1. A full list of cancer genes. Tumour Tumour Other Gene Gene full Entrez Chr Somat Germli Cancer Tissue Molecular Mut Translocati Other Chr Types Types Germline Syn Symbol name Gene ID Band ic ne Synd Type Genetics Types on Partner Synd (Somatic) (Germline) Mut Abl-interactor 10p11. ABI1; E3B1; ABI-1; ABI1 10006 10 yes AML L Dom T MLL 1 2 SSH3BP1; 10006 V-abl Abelson ABL1; p150; ABL; c- murine BCR; CML; ALL; ABL; JTK7; bcr/abl; v- ABL1 leukemia viral 25 9 9q34.1 yes L Dom T; Mis ETV6; T-ALL abl; P00519; 25; oncogene NUP214 ENSG00000097007 homolog 1 C-abl ABL2; ARG; RP11- oncogene 2; 1q24- 177A2_3; ABLL; ABL2 non-receptor 27 1 yes AML L Dom T ETV6 q25 ENSG00000143322; tyrosine P42684; 27 kinase Acyl-coa 2181; ASPM; synthetase PRO2194; ACS3; ACSL3 long-chain 2181 2 2q36 yes Prostate E Dom T ETV1 FACL3; O95573; family ENSG00000123983; member 3 ACSL3 CASC5; AF15Q14; AF15q14 Q8NG31; D40; AF15Q14 57082 15 15q14 yes AML L Dom T MLL protein ENSG00000137812; 57082 ALL1-fused MLLT11; Q13015; gene from AF1Q; AF1Q 10962 1 1q21 yes ALL L Dom T MLL chromosome ENSG00000213190; 1q 10962 SH3 protein Q9NZQ3; AF3P21; interacting WISH; ORF1; with Nck; 90 AF3p21 51517 3 3p21 yes ALL L Dom T MLL WASLBP; SPIN90; kda (ALL1 ENSG00000213672; fused gene NCKIPSD; 51517 from 3p21) 27125; Q9UHB7; ALL1 fused MCEF; AF5Q31; AF5q31 gene from 27125 5 5q31 yes ALL L Dom T MLL ENSG00000072364; 5q31 AFF4 KIAA0803; AKAP350; CG-NAP; MU-RMS- A kinase 40_16A; PRKA9; (PRKA) 7q21- Papillary AKAP9 10142 7 yes E Dom T BRAF YOTIAO; HYPERION; anchor protein q22 thyroid AKAP450; Q99996; (yotiao) 9 ENSG00000127914; 10142; AKAP9 P31749; AKT1_NEW; 207; V-akt murine Breast; ENSG00000142208; thymoma viral 14q32.
    [Show full text]